in

Roflumilast Promising for AD in Children Down to Age 3 Mos

Source link : https://newshealth.biz/health-news/roflumilast-promising-for-ad-in-children-down-to-age-3-mos/

Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/roflumilast-shows-promise-treating-atopic-dermatitis-2026a10009ia?src=rss Author : Publish date : 2026-03-28 16:34:00 Copyright for syndicated content belongs to the linked Source.

The post Roflumilast Promising for AD in Children Down to Age 3 Mos first appeared on News Health.

—-

Author : News Health

Publish date : 2026-03-28 16:34:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Jake Paul Sets Sights on Late-Year Boxing Return and Epic MMA Clash with Oleksandr Usyk

Senegal Stripped of Africa Cup Title, Morocco Crowned New Champions in Stunning Turnaround